Navigation Links
Adherence to Angioplasty/Stent Guidelines Lacking: Study
Date:7/11/2011

MONDAY, July 11 (HealthDay News) -- Many U.S. hospitals don't follow recently revised guidelines for the appropriate use of balloon angioplasty and stenting in patients who have a blocked coronary artery after a heart attack, a new study finds.

A U.S. National Heart, Lung, and Blood Institute study released in 2006, called the Occluded Artery Trial (OAT), found that angioplasty and stenting -- known as percutaneous coronary intervention (PCI) -- had little effect on patients with blocked coronary arteries that were detected more than 24 hours after a heart attack. As a result, the American Heart Association and American College of Cardiology revised their guidelines for PCI in such situations.

In this study, researchers analyzed data from 28,780 patient visits at 896 U.S. hospitals between 2005 and 2008 in order to determine whether clinical practice changed after the release of the study findings and the updated guidelines.

PCI was performed on 11,083 patients before the OAT study was published, 7,838 between the release of the study and guideline changes, and 9,859 after the guidelines were revised, the investigators found.

After they factored in other variables, the study authors found no overall significant decrease in the monthly rate of PCI performed for coronary blockages either after the OAT results were published or after the guidelines were updated.

"In conclusion, among this large cross-section of hospitals in the United States we found only modest evidence that the results of the OAT and its incorporation into major guideline revisions have influenced cardiology and interventional cardiology practice over the subsequent one to two years," wrote Dr. Marc W. Deyell, of the University of British Columbia in Vancouver, Canada, and colleagues.

"Percutaneous coronary intervention of total occlusions identified greater than 24 hours after [heart attack] remains commonplace despite little evidence to support its use in stable patients and new clinical practice guidelines recommending against it," the researchers reported in the July 11 online edition of the journal Archives of Internal Medicine.

The findings mean that many patients may be undergoing an expensive procedure that does not help them, the study authors explained in a journal news release about the report, which is part of the journal's Less Is More series.

A number of factors, including difficulties in changing doctors' and patients' beliefs and behaviors, may play a role in the lack of adherence to the revised guidelines, Dr. Mauro Moscucci, from the University of Miami's Miller School of Medicine, pointed out in a commentary accompanying the study.

The findings add to the spotlight being placed on procedures that increase health care costs without providing a clear benefit to patients, he noted.

"While the debate on health care reform is ongoing, health care expenditures in the United States are continuing to escalate. Thus, we must heed the call to professional responsibility aimed at the elimination of tests and treatments that do not result in any benefit for our patients, and for which the net effects will be added costs, waste and possible harm," Moscucci said.

Commenting on the study, Dr. Barry Kaplan, vice chairman of cardiology at North Shore University Hospital in Manhasset, N.Y., and Long Island Jewish Medical Center in New Hyde Park, N.Y., had this to say: "The guidelines were updated based on the OAT results in December 2007. In all medical fields there is usually a one- to two-year lag between the changes in recommendations by agencies such as AHA and ACC and adoption and acceptance of these guideline changes by practicing physicians. This study examined trends from 2005 to 2008 and may have been done too early in order to capture a change in practice."

In addition, "this study does not account for technological advances in PCI and other cardiac testing that occurred between the time period when OAT was enrolling patients and the time period when this study examined changes in trends," said Kaplan, who was not involved with the study. "For example, after 2004 the use of drug-eluting stents has markedly improved the durability of the PCI result, which may have favorably altered outcomes in OAT [study] patients," he explained.

More information

The U.S. National Heart, Lung, and Blood Institute has more about coronary angioplasty.

-- Robert Preidt

SOURCES: Archives of Internal Medicine, news release, July 11, 2011; Barry Kaplan, M.D., vice chairman of cardiology, North Shore University Hospital in Manhasset, N.Y. and Long Island Jewish Medical Center in New Hyde Park, N.Y.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researchers develop strategy to improve patient adherence
2. Depression associated with poor medication adherence in patients with chronic illnesses
3. Study in PLoS: Intensive adherence counseling to HIV treatment improves patient outcomes
4. Adherence course reduces hypertension
5. Side effects of hormonal breast cancer therapy increased; may affect treatment adherence
6. Medication adherence improves blood pressure control in chronic kidney disease
7. Adherence to practice guidelines may reduce bleeding in cirrhosis patients
8. Electronic Monitoring of Asthma Med Use May Boost Adherence
9. NACDS RxIMPACT "Hill Day" Features More Advocates Increased Focus on Medication Adherence
10. Clinically Relevant Technologies Releases New Medical iPhone App To Fill Gap In Adherence To Low Back Pain Management Guidelines
11. International Vasospasm 2011 conference could be springboard for treatment guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Adherence to Angioplasty/Stent Guidelines Lacking: Study 
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... a new partnership with the Rhode Island Consortium for Autism Research and Treatment ... opportunity for children with autism spectrum disorder (ASD) to see films in an ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... ... February 22, 2017 , ... When ... new healthcare contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. ... healthcare systems recently invested $51 million to purchase and renovate the 185,000 square-foot ...
(Date:2/22/2017)... Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... detox treatment to the thousands of individuals who have recently fallen victim to America’s ... hospital in Orange County, California, where they are free from the shame, stigma, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... leads to fewer trips the emergency room, fewer hospital admissions, and better blood ... of Managed Care® (AJMC®) finds. The study can be found here . ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017   SeraCare Life ... global in vitro diagnostics manufacturers and clinical laboratories, ... "Catalyzing Implementation of NGS-Based Tests" to be hosted ... 2017 at 11am Eastern Standard Time (US). ... highlight the need for improved performance and global ...
(Date:2/23/2017)... -- ML Capital Group, Inc. (USOTC: MLCG) today announced ... , a Colorado -based cannabis tourism company. ... (USOTC: PURA) to enter Colorado,s $19 billion ... Tours acquisition announced today is intended to accelerate MLCG,s ... ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... a clinical-stage oncology drug development company, announces that ... and Drug Administration (FDA) authorizing the initiation a ... therapeutic treatment for pancreatic cancer. MVT-1075 ( 177 ... radioimmunotherapy (RIT). MabVax plans to initiate the phase ...
Breaking Medicine Technology: